Teneligliptin hydrobromide - CAS 906093-29-6

Teneligliptin hydrobromide (MP-513 (hydrobromide) ) is a novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor; competitively inhibited human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50 values of approximately 1 nM.

Interleukin, ROS, DPP-4, NF-κB, Proteasome, p38 MAPK, Apoptosis, AMPK, JNK, NOD-like Receptor (NLR), Immunology/Inflammation related

Proteases/Proteasome, Chromatin/Epigenetic, NF-κB, PI3K/Akt/mTOR signaling, Immunology/Inflammation, Ubiquitination, MAPK, Apoptosis

906058

>99.99%

C22H30N6OS·5/2BrH

628.86

Br.Br.Br.Br.Br.Cc1cc(N2CCN(CC2)C2CNC(C2)C(=O)N2CCSC2)n(n1)-c1ccccc1.Cc1cc(N2CCN(CC2)C2CNC(C2)C(=O)N2CCSC2)n(n1)-c1ccccc1

-20°C

Ice Packs

Small Compound